Alan B. Lancz & Associates’s CME Group CME Stock Holding History

Alan B. Lancz & Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Hold	1,575	–	–	0.3%	84
2026 Q1	$465K	Sell	1,575 -450	-22%	-$134K	0.45%	61
2025 Q4	$553K	Hold	2,025	–	–	0.49%	52
2025 Q3	$547K	Hold	2,025	–	–	0.49%	48
2025 Q2	$558K	Hold	2,025	–	–	0.56%	43
2025 Q1	$537K	Hold	2,025	–	–	0.57%	46
2024 Q4	$470K	Sell	2,025 -600	-23%	-$138K	0.48%	52
2024 Q3	$579K	Hold	2,625	–	–	0.53%	47
2024 Q2	$516K	Buy	+2,625	New	+$542K	0.51%	45
2023 Q4	$553K	Sell	2,625 -100	-4%	-$21.3K	0.58%	39
2023 Q3	$546K	Sell	2,725 -100	-4%	-$19.9K	0.62%	40
2023 Q2	$523K	Hold	2,825	–	–	0.56%	48
2023 Q1	$541K	Hold	2,825	–	–	0.56%	46
2022 Q4	$496K	Hold	2,825	–	–	0.5%	56
2022 Q3	$500K	Hold	2,825	–	–	0.59%	43
2022 Q2	$564K	Sell	2,825 -100	-3%	-$21.2K	0.56%	42
2022 Q1	$696K	Hold	2,925	–	–	0.62%	38
2021 Q4	$668K	Buy	+2,925	New	+$644K	0.58%	46

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Alan B. Lancz & Associates's CME Position: Q2 2026 in Review

Alan B. Lancz & Associates held its CME Group (CME) position steady in Q2 2026 at 1,575 shares worth $348K. The position accounts for 0.3% of the portfolio, ranked #84.

Alan B. Lancz & Associates first reported a position in CME in Q4 2021 and has held it in 18 quarters since. The position peaked at $696K in Q1 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Alan B. Lancz & Associates held 1,575 shares of CME Group worth $348K as of Q2 2026.
Alan B. Lancz & Associates left its CME Group share count unchanged in Q2 2026.
CME Group made up 0.3% of Alan B. Lancz & Associates's portfolio in Q2 2026, its #84 holding.
Alan B. Lancz & Associates first reported a position in CME Group in Q4 2021 and has held it in 18 quarters since.
Alan B. Lancz & Associates's CME Group position peaked at $696K in Q1 2022.
1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.